Highlights
Union Health Minister Harsh Vardhan urged states to first focus more on second dose COVID-19 vaccinations.
While 13.66 crore people have been administered the first dose, the second dose has been administered to only 3.86 crore.
The Serum Institute and Bharat Biotech have submitted their production plan for the next four months to the central government.
New Delhi: Due to the acute shortage of COVID-19 vaccines in the country, many states have temporarily suspended the vaccination drive for the people in the age group of 18 to 44 and have directed the available stock of doses for the above-45 age group.
Maharashtra on Wednesday (May 12, 2021) decided to suspend its third phase of vaccination drive, while Delhi also temporarily shut Covaxin administering centres for people in the age group of 18 to 44 years as it has run out of stock.
Biocon chief expresses concern over COVID-19 vaccine shortage
India has announced expansion of its COVID-19 vaccination drive by allowing its large population aged over 18 to get inoculated from May 1.
Share Via Email
| A+A A- By PTI
NEW DELHI: Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn.
India has announced expansion of its COVID-19 vaccination drive by allowing its large population aged over 18 to get inoculated from May 1. Very concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn, Mazumdar-Shaw said in a tweet on Tuesday while tagging the Health Ministry
Synopsis Very concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn, Mazumdar-Shaw said in a tweet on Tuesday while tagging the Health Ministry.
Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines
Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn.
Biocon chief fears vaccines remain in warehouses instead of being jabbed into peoplesâ arms
BL Soni
Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over the shortage of COVID-19 vaccines. She stated that maybe these vaccines are just lying in the warehouse rather than reaching people. She feels this lacuna can only be addressed by bringing in better transparency.
Mazumdar-Shaw said in a tweet on Tuesday while tagging the Health Ministry, wrote, âVery concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn.
The company has already roped in 23,000 volunteers for the trials, it said. The company statement has come after anexpert panel of India s central drug authority recommended granting permission for restricted use of Covaxin in emergency situation, especially in the context of infection by mutant strains. The recommendation for Bharat Biotech s vaccine came a day after the panel cleared the Serum Institute of India s emergency use authorisation application for the Oxford-AstraZeneca vaccine Covishield, paving the way for the rollout of COVID-19 shots in the country in the next few days. Bharat Biotech, Serum Institute and Pfizer had applied with the Drug Controller General of India (DCGI) for emergency use authorisation for their respectivevaccines.